UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): September 10, 2007
The Medicines Company
(Exact Name of Registrant as Specified in Charter)
Delaware | | 000-31191 | | 04-3324394 |
(State or Other Jurisdiction | | (Commission | | (IRS Employer |
of Incorporation) | | File Number) | | Identification No.) |
8 Campus Drive | | |
Parsippany, New Jersey | | 07054 |
(Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (973) 656-1616
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
The Medicines Company (the “Company”) filed a Current Report on Form 8-K on September 10, 2007 (the “September 10th Form 8-K”) in which the Company furnished slides to be presented at the Bear Stearns 20th Annual Healthcare Conference on September 10, 2007. The Company is filing this amendment to the September 10th Form 8-K to revise two slides furnished in the September 10th Form 8-K. The two revised slides are furnished as Exhibit 99.1 to this amendment to the September 10th Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 Revised Presentation Slides for the Bear Stearns 20th Annual Healthcare Conference on September 10, 2007.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| THE MEDICINES COMPANY |
| |
| |
Date: September 11, 2007 | By: | /s/ Paul M. Antinori | |
| | Paul M. Antinori |
| | Senior Vice President and General Counsel |
3
Exhibit Index
Exhibit No. | | Description |
| | |
99.1 | | Revised Presentation Slides for the Bear Stearns 20th Annual Healthcare Conference on September 10, 2007 |
4
